IPD
IMPEDIMED FPO [IPD]
Healthcare · ASX Small Cap
$0.0150 +0.0%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical52
Catalyst50
Sentiment50
Fundamental90
Momentum39
Risk Gate27
Get alerts when IPD's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- Stochastic is deep in oversold territory — bounce conditions forming
- Sitting near support — this level has held before and could attract buyers again
- Drifting lower — down 6.3% over the last 5 days
- Volatility is contracting — like a spring being compressed, breakouts often follow
- Adequate cash runway (5 quarters)
- Low P/S ratio (2.1x)
- Strong revenue growth (+25%)
- EPS estimates revised upward (+10pts)
- Near 52-week low (0% of range)
- Small-cap ($20-100M)
- CANSLIM I: Institutional ownership (15%)
- Turned profitable (NPAT positive from results)
- Sentiment is mixed — no strong consensus either way
- Altman Z-Score distress zone (0.34 < 1.81, low-confidence approx)
- Penny stock risk ($0.015)
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Piotroski F-Score weak (3/9, low-confidence approx)
- Deeply negative margins (-171%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Long-term momentum is negative — down 40% over the past year
- The bigger volume days are the down days — volume-weighted momentum is negative (-8.54%/day)
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about IPD
3 free messages/day · Unlimited with Pro
Recent Catalysts
LOW FY26 H1 Results Investor Presentation
NONE FY26 Half Year Financial Results
NONE Appendix 4D and Interim Financial Report
NONE Initial Director's Interest Notice - Mr Erik Anderson
Recent ASX Announcements
| 2026-03-02 | FY26 H1 Results Investor Presentation |
| 2026-02-25 | FY26 Half Year Financial Results PRICE SENSITIVE |
| 2026-02-25 | Appendix 4D and Interim Financial Report PRICE SENSITIVE |
| 2026-02-25 | Initial Director's Interest Notice - Mr Erik Anderson |
| 2026-02-25 | Appointment of Independent Non-executive Director |
Key Metrics
$30.6M
Market Cap
2.6M
Avg Volume
0.7x
Vol Ratio
$0.01 — $0.06
52-Week Range
0.6%
Short Interest
N/A
Cash Runway
-117.9%
ROE
-171.3%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 89% |
| L | Leader vs Laggard | laggard | RS: -13 |
| I | Institutional Sponsorship | pass | Inst: 15% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #61 of 117 · Sector avg: 46
View all Healthcare signals →Track IPD and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required